Insights Hub

台灣自費藥品市場趨勢觀察

Read More
IpsosPersonaBot

認識 Ipsos PersonaBot,助力市場區隔升級

Show more
Healthcare Vs Evolution: Can GLP-1s Rewrite Our Evolutionary Story?
醫療保健

醫療 VS 演化:GLP-1 能否改寫我們的演化歷程?

Show more

All content

  • Publication

    Time to Decide

    Measuring response time for innovation and brand growth.
  • Publication

    Towards more agile and efficient product testing

    Opportunities and limitations for small sample sizes
  • Publication

    Ipsos Omnibus is now available on the Ipsos.Digital Platform

    A fast, cost-effective, reliable solution available in DIY or DIY assisted mode
  • Publication

    Flirtation or commitment: Assessing post-pandemic stickiness of product subscriptions

    Product subscriptions have gained a new relevance during the pandemic,but will this behaviour stick in a post COVID-19 world?
  • Publication

    The Retail Rollercoaster

    Riding the ups and downs of today’s omnichannel shopper landscape
  • Publication

    Consumer Consciousness

    A new survival strategy in an increasingly volatile world
  • Publication

    Trading Up

    How has the pandemic impacted the positive momentum of premium brands?
  • Publication

    We d̶o̶n̶'̶t need to talk about ads

    Why only some advertising gets talked about on social media and becomes famous
  • Covid-19 Publication

    英國與美國新冠肺炎疫苗接種意願提升

    益普索與世界經濟論壇最新合作的調查資料顯示,在美國與英國開始施打第一支疫苗後,這兩個國家民眾接種新冠疫苗的意願也隨之提升。
  • 美妝 Publication

    美妝市場十大趨勢

    美妝產業因電商和社交平台快速發展,加上群眾影響力高的KOL (關鍵意見領袖),越來越多的消費者因為被直播主推薦而開始關注與追求 「美」。美已不再是悅己者容,在顏值經濟的推動下,更帶動了美妝產業的發展。
  • Covid-19 Publication

    疫情之下,如何拯救體驗經濟

    即便新冠肺炎疫苗問世,整個體驗經濟仍面臨挑戰。儘管即將開始啟動疫苗緊急接種計畫,官方對2021年讓疫苗獲得普及仍持懷疑態度。最新的新聞顯示,即使新冠肺炎疫苗能產生高度作用,美國新冠肺炎感染人數的急劇上升燃起民眾對疫苗的熱切期待,但還要多久才能得到疫苗並擴大疫苗接種人群還有待觀察。
  • Covid-19 Publication

    企業防疫策略思維,以保持獲利

    各國面臨新一波Covid-19疫情的挑戰,確診數的回升意味著經濟復甦將比預期來得更加遙遠。全球有四成的民眾認為一年內生活無法回歸正常狀態。另外,有六成的美國民眾則不相信疫苗效用因為它太快進入審核流程。因此,對品牌來說,該採取什麼樣的方式來因應?